Chronic Myeloid Leukemia Diagnosed during Pregnancy: Therapy, Outcomes and Follow-up

ConclusionCML may be diagnosed at any pregnancy stage and pregnancy termination/prolongation should be judged individually. A normal childbirth may take place including cases with use of IM at late pregnancy. It is reasonable to adjust therapy options to pregnancy trimester and to avoid potential teratogenic drugs at 1st trimester. A careful follow-up and timely monitoring of these cases is needed.DisclosuresChelysheva: Fusion Pharma: Other: provided consultations ; Bristol Myers Squibb: Other: provided consultations and performed lectures; Novartis: Other: provided consultations and performed lectures. Abruzzese: Pfizer: Consultancy; BMS: Consultancy; Novartis: Consultancy; Ariad: Consultancy. Rea: Novartis: Honoraria, Membership on an entity's Board of Directors or advisory committees; Incyte: Honoraria; Bristol-Myers Squibb: Honoraria, Membership on an entity's Board of Directors or advisory committees; Pfizer: Honoraria. Kim: BMS: Research Funding; Pfizer: Research Funding; Novartis: Research Funding; Ilyang: Research Funding. Chabaeva: Russian Foundation for Basic Research grant 18-015-00399 A: Research Funding. Kulikov: Russian Foundation for Basic Research grant 18-015-00399 A: Research Funding. Turkina: Novartis: Other: provided consultations; Bristol Myers Squibb: Other: provided consultations; Phizer: Other: provided consultations; Fusion Pharma: Other: provided consultations.

Source: Blood - November 21, 2018 Category: Hematology Authors: Chelysheva, E., Abruzzese, E., Rea, D., Kim, D.-W., Kazakbaeva, K., Saliev, S., Kotlyarchuk, K., Polushkina, E., Shmakov, R., Chabaeva, J., Kulikov, S. M., Turkina, A. G. Tags: 632. Chronic Myeloid Leukemia: Therapy: Poster III Source Type: research